| scholarly article | Q13442814 |
| P2093 | author name string | Cong Liu | |
| Xue Bai | |||
| Yanfei Ren | |||
| Xuyang Zhao | |||
| Shicheng Wei | |||
| Jianguo Ji | |||
| Qingsong Wang | |||
| Zeyang Li | |||
| Xuefei Zhang | |||
| Zheyi Li | |||
| Xiaoqing Ren | |||
| Lingfang Tang | |||
| P2860 | cites work | Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma | Q24647476 |
| Mass spectrometry-based proteomics turns quantitative | Q28291379 | ||
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
| Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 | ||
| The polycomb group protein EZH2 is involved in progression of prostate cancer | Q29614514 | ||
| 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data | Q30578327 | ||
| Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. | Q31413445 | ||
| Resveratrol protects against global cerebral ischemic injury in gerbils | Q33185381 | ||
| Global genomic and proteomic analysis identifies biological pathways related to high-risk neuroblastoma | Q33571893 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes | Q33794127 | ||
| 2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics | Q33882364 | ||
| Regulation of tumor angiogenesis by EZH2. | Q34073170 | ||
| Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. | Q34561758 | ||
| Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells | Q34570302 | ||
| Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells | Q34619655 | ||
| The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? | Q35008935 | ||
| ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux. | Q35166695 | ||
| Neuroblastoma: evolving therapies for a disease with many faces | Q35702126 | ||
| GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists | Q35724720 | ||
| Targeting the enhancer of zeste homologue 2 in medulloblastoma. | Q36032753 | ||
| EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR | Q36365753 | ||
| Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells | Q36670103 | ||
| Neuroblastoma and MYCN | Q37201479 | ||
| p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients | Q37208850 | ||
| Neuroblastoma: biology, prognosis, and treatment | Q37683919 | ||
| Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. | Q37822876 | ||
| MicroRNAs in neuroblastoma: small-sized players with a large impact | Q38183288 | ||
| The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. | Q38333661 | ||
| A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics | Q38510457 | ||
| c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage | Q39068117 | ||
| Preferential binding of p53 tumor suppressor to p21 promoter sites that contain inverted repeats capable of forming cruciform structure | Q39077494 | ||
| MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. | Q39196320 | ||
| Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. | Q39480825 | ||
| MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes | Q39557396 | ||
| Resveratrol regulates the expression of NHE-1 by repressing its promoter activity: critical involvement of intracellular H2O2 and caspases 3 and 6 in the absence of cell death | Q39925144 | ||
| Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop | Q40308316 | ||
| Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid | Q40527498 | ||
| Resveratrol arrests the cell division cycle at S/G2 phase transition | Q41009414 | ||
| Morphological and biochemical characterization and analysis of apoptosis | Q41582799 | ||
| Red wine micronutrients as protective agents in Alzheimer-like induced insult. | Q44363756 | ||
| Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma | Q44405256 | ||
| Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma | Q44846786 | ||
| The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells | Q45152785 | ||
| Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. | Q53423631 | ||
| Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. | Q55239231 | ||
| Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study | Q70222879 | ||
| Significance of chromosome 1p loss of heterozygosity in neuroblastoma | Q71729157 | ||
| P433 | issue | 2 | |
| P921 | main subject | neuroblastoma | Q938205 |
| P304 | page(s) | 316-328 | |
| P577 | publication date | 2014-12-11 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells | |
| P478 | volume | 14 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q48152957 | Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation |
| Q36576975 | Dietary components as epigenetic-regulating agents against cancer |
| Q91756244 | Low expression levels of plasma miR-141 are associated with susceptibility to gastric cancer |
| Q34538870 | MicroRNA Methylation in Colorectal Cancer |
| Q42235455 | MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2. |
| Q48168117 | MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer. |
| Q99629189 | MicroRNA449c Mediates the Generation of moMDSCs by Targeting STAT6 |
| Q26797487 | MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy |
| Q41684014 | MicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants |
| Q92193233 | MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution |
| Q47388075 | MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2. |
| Q37633731 | Neuroblastoma treatment in the post-genomic era. |
| Q37590445 | Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver. |
| Q41573279 | Polycomb Repressor Complex 2 in Genomic Instability and Cancer |
| Q51418370 | Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology. |
| Q38702262 | Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer |
| Q38832561 | Resveratrol inhibits the hydrogen dioxide-induced apoptosis via Sirt 1 activation in osteoblast cells |
| Q38998623 | Towards diagnostic application of non-coding RNAs in neuroblastoma |
| Q98182369 | miR-137: A Novel Therapeutic Target for Human Glioma |
| Q47148750 | miR-449a inhibits colorectal cancer progression by targeting SATB2. |
| Q100430026 | miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets |
Search more.